Antiproliferative Effect of Lanreotide in Low Grade Neuroendocrine Neoplasms: Two Case Reports

#1085

Introduction: Somatostatin analogs are used for control of symptoms due to hormonal hypersecretion by neuroendocrine neoplasms (NEN). Their antiproliferative effect only recently became evident. Data on pancreatic NEN (pNEN) are limited.

Aim(s): We present patients with pNEN that received Lanreotide.

Materials and methods: 2 case reports

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Vaslamatzis M, Tegos T, Alevizopoulos N, Stathopoulos C, Argyrakos T,

Keywords: NEN, lanreotide,